Blog

There are a number of possible explanations for this result. (ORF1p and ORF2p). Consistently, confocal immunofluorescent microscopy demonstrated that WT RNase L, but not RNase L R667A, prevented formation of L1 cytoplasmic foci. Finally, siRNA-mediated depletion of endogenous RNase L in a human ovarian cancer cell line (Hey1b) increased the levels of L1 retrotransposition by 2-fold. Together, these data suggest that RNase L might function as a suppressor of structurally distinct retrotransposons. == INTRODUCTION == Transposable elements comprise at least 45 and 37.5% of the human and mouse genomes, respectively (1,2). They are classified by whether they replicate via a DNA (transposons) or an RNA intermediate (retrotransposons) [reviewed in (3)]. DNA transposons originally were discovered in maize as mutable loci capable of mobilizing to new genomic locations (3,4). DNA transposons comprise 3% of the human genome (1) and were active during primate evolution until 37 million years ago (5). However, with the exception of certain bat species (6), DNA transposons appear to be inactive in most mammalian genomes (1). Unlike 3-Hydroxyhippuric acid the cut-and-paste mobility mechanism used by DNA transposons, retrotransposons mobilize via a copy-and-paste mechanism that uses an RNA intermediate [reviewed in (7)]. There are two major groups of retrotransposons that are distinguishable by the presence or absence of long terminal repeats (LTRs). LTR-retrotransposons include human being endogenous retroviruses (HERVs) as well as murine intracisternal A-particle (IAP) and MusD sequences [examined in (810)]. Endogenous LTR-retrotransposons are structurally much like retroviruses, but generally lack or contain a defective envelope (env) gene, which relegates them to intracellular replication [examined in (11)]. While HERVs look like inactive in the human being genome, it is estimated that 300 copies of IAP and 10 copies of MusD remain practical in the mouse genome (1214). Non-LTR retrotransposons, including Very long INterspersed Element-1 (Collection-1 or L1) and the Small INterspersed Elements (SINEs), account for about one-third of human being genomic DNA (1). L1 elements are the only class of autonomously active human being retrotransposons [examined in (10)]. The L1-encoded proteins (ORF1p and/or ORF2p) can also mobilize particular SINEs (e.g. Alu and SVA elements) (10,1517). Importantly, L1-mediated retrotransposition events continue to cause insertional mutagenesis and genetic disorders in humans [examined in (18)]. Human being L1 sequences represent 17% of human being genomic DNA (1). While the vast majority of L1s are molecular fossils incapable of retrotransposition, it is estimated that 80100 L1s remain retrotransposition-competent (19,20). Full-length human being L1s are 6 kb in length (21,22). They contain an internal sense-strand promoter (SP) located within their 5-untranslated region (UTR) (2327). Transcription generates a bicistronic mRNA that consists of the L1 5-UTR, two open reading frames (ORF1 3-Hydroxyhippuric acid Rabbit Polyclonal to OR1L8 and ORF2) and a 3-UTR that ends in a poly (A) tail (21,22). The L1 5-UTR also contains an antisense promoter (ASP), which drives the production of an RNA containing a region of the 5-UTR conjoined to an mRNA sequence derived from genomic sequences located upstream of the L1 integration site (28) [observe pJM101/L1.3 gene map inFigure 1A (top)]. == Number 1. == An overview of the L1 and IAP retrotransposition assays. (A) Schematics of L1 and IAP constructs: The L1 and IAP constructs contain a NEO-based (mneoI) orEGFP-based (mEGFPI) retrotransposition indication cassette near their 3 ends. The indication cassettes are in an anti-sense (backward) orientation relative to the transcriptional orientation of the L1 or IAP elements. The indication cassettes also contain an intron that 3-Hydroxyhippuric acid is in the same transcriptional orientation as the retroelement. SD and SA indicate the splice donor and splice acceptor sites of the intron, respectively. Pr shows the promoter traveling the expression of the retrotransposition indication cassette. Closed lollipops show the polyadenylation transmission on the indication cassette. A CMV promoter enhances the manifestation of the pJM101/L1.3, pAD2TE1, pES2TE1 and pAD3TE1 L1 vectors. An SV40 polyadenylation transmission is present in the 3 end of each L1 manifestation cassette. Notably, themneoI-based L1 vectors are indicated from a pCEP4 vector that contains a HYG and an EBNA-1 3-Hydroxyhippuric acid gene. ThemEGFPI-basedL1 vectors are indicated from a pCEP4 vector that 3-Hydroxyhippuric acid was altered to contain a PURO gene; it also contains the EBNA-1 gene. Flag symbols show the titles of epitope-tags present in some L1 vectors. The SP and ASP.